Skip to content
WeighLab
Menu
Ranked #282 · Grade C

Invyncible review

Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.

Visit Invyncible Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$192/mo (0.5 mg dose, compounded)
Tirzepatide
$210/mo (compounded)
Coverage
40 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,304

Tirzepatide · modeled / year

$2,520

The Index scorecard

Invyncible scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month56/100
Price Transparency30/100
Nationwide Access66/100
Formulation Options66/100
Clinical Oversight70/100
Contract Flexibility61/100

Where the value is

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

The tradeoffs

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

The bottom line

Best for: Cost-first shoppers who want corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal. Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.

Ranked #282 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Invyncible.

The 18 programs nearest this one

Pricing, states and verification reflect Invyncible's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Invyncible's site. Not medical advice; see our disclosure.

← Back to the value leaderboard